lestaurtinib has been researched along with Cell Transformation, Neoplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, JY; Baird, K; Kim, KT; Levis, M; Lilly, M; Meltzer, P; Small, D | 1 |
| Cheng, L; Kim, KT; Levis, M; Li, L; Nguyen, HB; Piloto, O; Small, D; Ye, Z; Yu, X | 1 |
2 other study(ies) available for lestaurtinib and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival.
Topics: Animals; Apoptosis; Carbazoles; Cell Line; Cell Line, Transformed; Cell Line, Tumor; Cell Survival; Cell Transformation, Neoplastic; fms-Like Tyrosine Kinase 3; Furans; Humans; Indoles; Membrane Proteins; Mice; Mutation; Protein Serine-Threonine Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-pim-1; Receptor Protein-Tyrosine Kinases; Repetitive Sequences, Nucleic Acid; RNA; Up-Regulation | 2005 |
FLT3/ITD expression increases expansion, survival and entry into cell cycle of human haematopoietic stem/progenitor cells.
Topics: Antigens, CD34; Antineoplastic Agents; Carbazoles; Cell Cycle; Cell Differentiation; Cell Line, Transformed; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cyclin D3; Cyclins; fms-Like Tyrosine Kinase 3; Furans; Gene Expression; Genes, myc; HIV-1; Humans; Indoles; Leukemia, Myeloid, Acute; Proto-Oncogene Proteins c-pim-1; Stem Cells; Transduction, Genetic; Transfection | 2007 |